Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Completed 2Unknown 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 2Breast 1

Conditions

Uterine Cervical Neoplasms 2Lymphedema 1Breast Neoplasms 1

Interventions

Cyclophosphamide 3155Cisplatin 3151Carboplatin 2929Paclitaxel 2671Radiotherapy 2643Gemcitabine 2544pembrolizumab 2324Docetaxel 2154Bevacizumab 2126Fluorouracil 1819Capecitabine 1780Oxaliplatin 1709Dexamethasone 1589Nivolumab 1516Doxorubicin 1477Rituximab 1453Etoposide 1341Magnetic Resonance Spectroscopy 1261Irinotecan 1232Leucovorin 1212Cytarabine 1123Pemetrexed 1060Drug Therapy 1060fludarabine 1044Vincristine 956Specimen Handling 928Prednisone 924Cetuximab 919Lenalidomide 916Trastuzumab 897

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × specific substance maruyama × Clear all
NCT03476018 2022-06-16

Trial to Optimally Show the Pharmacological Action of Z-100

Zeria Pharmaceutical

Phase 3 Completed
72 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT02247232 2022-03-04

Randomized Study of Z-100 Plus Radiation Therapy to Treat Cervical Cancer

Zeria Pharmaceutical

Phase 3 Completed
793 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT04596683 2020-10-22

Same-Day Discharge After Nipple-sparing Mastectomy or Skin-sparing Mastectomy With Breast Reconstruction

Georgetown University

Phase NA Unknown
60 enrolled
Breast

Breast Neoplasms, Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡